About the AWG
Founded in 2012, AWG is an industry led 501(c)(6) organization that promotes the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging infectious disease companies. Today, AWG is comprised of fourteen different antimicrobial development companies and works through The Conafay Group, a life-sciences government relations firm based in Washington D.C. In seven years of work, we have maintained a sharp focus on sustained support for antimicrobial research and development, enhanced reimbursement, expedited approval pathways, and sound stewardship measures based on appropriate use.
AWG’s mission is to improve the regulatory, investment, and commercial environment for antimicrobial drug and diagnostic device development to provide doctors and patients with innovative infectious disease treatment options.